Soluble p-selectin and the risk of primary graft dysfunction after lung transplantation

Chest. 2009 Jul;136(1):237-244. doi: 10.1378/chest.08-2697. Epub 2009 Mar 2.

Abstract

Background: Platelet activation with subsequent neutrophilic adherence to the vasculature initiates ischemia-reperfusion injury. We hypothesized that higher plasma P-selectin levels reflecting platelet activation would therefore be associated with primary graft dysfunction (PGD) after lung transplantation.

Methods: In a prospective, multicenter cohort study of 376 patients who had undergone lung transplantation between 2002 and 2007, we measured soluble P-selectin levels before lung transplantation and at 6 and 24 h after lung reperfusion in 20 patients with grade III PGD (Pao(2)/fraction of inspired oxygen, < 200 mm Hg [with alveolar infiltrates seen on chest radiographs]) at 72 h after transplantation and 61 control subjects without PGD.

Results: Higher postoperative soluble P-selectin levels were associated with an increased risk of PGD at 72 h after transplantation (odds ratio [OR] per 1 natural log increase in soluble P-selectin at 6 h after lung allograft reperfusion, 3.5; 95% confidence interval [CI], 1.01 to 11.8; p = 0.048) and at 24 h after lung allograft reperfusion (OR, 4.8; 95% CI, 1.4 to 16.1; p = 0.01). Higher preoperative mean pulmonary artery pressure and the use of cardiopulmonary bypass were also associated with an increased risk of PGD.

Conclusion: Higher postoperative soluble P-selectin levels were associated with an increased risk of PGD at 72 h following lung transplantation.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Case-Control Studies
  • Cohort Studies
  • Female
  • Humans
  • Logistic Models
  • Lung Diseases / blood*
  • Lung Diseases / pathology
  • Lung Diseases / surgery
  • Lung Transplantation / adverse effects*
  • Male
  • Middle Aged
  • P-Selectin / blood*
  • Platelet Activation
  • Primary Graft Dysfunction / blood*
  • Primary Graft Dysfunction / etiology*
  • Risk Factors

Substances

  • P-Selectin